Clarivate Plc
NYSE:CLVTInformation Technology Services
-$0.10 today
- Market cap
- $1.38B
- Beta
- 1.37
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$0.21
Volume 3.95M
Average 5.22M
CLVT Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Clarivate PlcNYSE: CLVT
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities falls 67.7% from a year ago
Other current liabilities stood at $100.6M at the end of Q1 FY2026, down 67.7% from a year earlier and down 31.4% from the prior quarter. Over 3 fiscal years it compounded at -23.4% a year.
Context
- Other current liabilities amounted to 0.9% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
- Other current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -67.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 146.7M USD
- Year-over-year change
- +812.1%
- 4-year CAGR
- -19.4%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 146.7M | +812.1% |
| FY2024 | 2024-12-31 | (20.6M) | -106.4% |
| FY2023 | 2023-12-31 | 321.9M | -1.4% |
| FY2022 | 2022-12-31 | 326.4M | -6.2% |
| FY2021 | 2021-12-31 | 348.01M | — |
Other Current Liabilities vs competitors
How CLVT compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -67.7% is the 6th highest of 7, against a peer median of -6.8%.
- Other current liabilities amounts to 0.9% of total assets for CLVT, versus a peer median of 2.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.52B USD | — | — | 20.6% | |
| Feb 2026 | $796.98M USD | +17.4% | +61.6% | 7.5% | |
| Mar 2026 | $143.06M USD | -10.6% | +14.2% | 4.4% | |
| Mar 2026 | $100.6M USD | -67.7% | -23.4% | 0.9% | |
| Mar 2026 | $63.33M USD | -3.1% | +8.8% | 1.7% | |
| Mar 2026 | $54.97M USD | — | +126.5% | 3.3% | |
| Apr 2026 | $17.64M USD | -62.5% | +6.2% | 2.2% | |
| Mar 2026 | $16.08M USD | -73.0% | +326.5% | 1.9% | |
| Jun 2026 | $10.15M USD | +586.9% | +23.7% | 2.8% | |
| Mar 2026 | CN¥0 CNY | — | -41.3% | 0.0% | |
| Peer median (excluding CLVT) | — | -6.8% | +18.9% | 2.8% | |
Competitors are the stored peer set for CLVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 587.61M | 348.8M | 370.7M | 295.2M | 329.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 906.43M | 872.1M | 908.3M | 798.3M | 821.7M |
| Inventory | 0 | 97.4M | 0 | 0 | 0 |
| Other Current Assets | 66.65M | 76.9M | 94.7M | 65.2M | 64.9M |
| Total Current Assets | 1.64B | 1.4B | 1.46B | 1.24B | 1.31B |
| Property, Plant & Equipment (Net) | 169.88M | 113.4M | 106.8M | 107.1M | 99.3M |
| Goodwill | 7.9B | 2.88B | 2.02B | 1.57B | 1.57B |
| Intangible Assets | 10.39B | 9.44B | 9.01B | 8.44B | 8.01B |
| Long-term Investments | 1.96M | 47.2M | 17.7M | 14.7M | 1.8M |
| Tax Assets | 27.94M | 24.2M | 46.7M | 48.5M | 17.2M |
| Other Non-current Assets | 48.75M | 50.7M | 43.1M | 67.5M | 66.3M |
| Total Non-current Assets | 18.55B | 12.55B | 11.24B | 10.25B | 9.76B |
| Total Assets | 20.18B | 13.94B | 12.71B | 11.49B | 11.07B |
| Account Payables | 129.22M | 101.4M | 144.1M | 124.5M | 150.6M |
| Short-term Debt | 62.75M | 26.7M | 24.4M | 20.6M | 101.5M |
| Tax Payables | 28.54M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.03B | 947.5M | 983.1M | 943.9M | 941.4M |
| Other Current Liabilities | 348.01M | 326.4M | 321.9M | (20.6M) | 146.7M |
| Total Current Liabilities | 1.9B | 1.56B | 1.6B | 1.43B | 1.57B |
| Long-term Debt | 5.46B | 4.97B | 4.72B | 4.52B | 4.32B |
| Deferred Tax Liabilities | 380.06M | 316.1M | 249.6M | 273.3M | 212.1M |
| Deferred Revenue (Non-current) | 54.25M | 38.5M | 38.7M | 16.6M | 0 |
| Other Non-current Liabilities | 370.59M | 171.4M | 41.9M | 55.9M | 86.2M |
| Total Non-current Liabilities | 6.36B | 5.57B | 5.11B | 4.92B | 4.66B |
| Total Liabilities | 8.26B | 7.13B | 6.71B | 6.35B | 6.23B |
| Common Stock | 11.83B | 11.74B | 11.74B | 12.98B | 12.81B |
| Retained Earnings | (1.6B) | (5.66B) | (6.65B) | (7.31B) | (7.51B) |
| Accumulated OCI | 326.76M | (665.9M) | (495.3M) | (526.3M) | (453.1M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 11.93B | 6.81B | 5.99B | 5.14B | 4.84B |
| Total Debt | 5.61B | 5.1B | 4.81B | 4.59B | 4.48B |
| Net Debt | 5.03B | 4.76B | 4.44B | 4.3B | 4.15B |
Clarivate Plc
NYSE:CLVT
Intrinsic Alpha fair value
Locked
Current Price
$2.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.